U.S. puts Israel on intellectual property watch list

05/2/2005 | Globes (Israel)

Israel had been off the list since 2003, but the latest priority watch list for 2005 from the U.S. Trade Representative's office cites the Mideast country, apparently because of a dispute between the two countries over Israel's protection of pharmaceutical intellectual property. The trade representative's office said progress had been made in negotiations during the past year, but Israel failed to meet U.S. demands. But Israel's chief negotiator said the watch list decision was the result of "brutal pressure" by U.S. drug companies.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA